Condition: Breast Cancer · Germ Cell Tumor · Sponsor: Jules Bordet Institute
Prospective longitudinal, single-center, non-randomized study for the implementation of an integrated multidisciplinary fatigue follow-up for young patients with breast cancer or germ cell tumour
This description comes directly from the study's public registry record.
Laura Polastro, MD · +3225413279 · laura.polastro@bordet.be
Always discuss trial participation with your own doctor first.
| Institut Jules Bordet | Brussels, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05502224